News

In 2018, Chinese biophysicist He Jiankui engaged in gene-hacking experiments using CRISPR technology. He used it to edit the ...
Chimeric antigen receptor (CAR) T cell therapies have revolutionized the treatment of haematological malignancies; however, their application in solid tumors remains challenging. CAR technology ...